Current state of nanomedicine drug products: An industry perspective

JD Clogston, W Foss, D Harris, H Oberoi, J Pan… - Journal of …, 2024 - Elsevier
Nanomedicine drug products have reached an unprecedented high in terms of global
commercial acceptance and media exposure with the approvals of the mRNA COVID-19 …

[HTML][HTML] Spectral insights: Navigating the frontiers of biomedical and microbiological exploration with Raman spectroscopy

ES Allakhverdiev, BD Kossalbayev… - … of Photochemistry and …, 2024 - Elsevier
Raman spectroscopy (RS), a powerful analytical technique, has gained increasing
recognition and utility in the fields of biomedical and biological research. Raman …

The Utilization of Plant-Material-Loaded Vesicular Drug Delivery Systems in the Management of Pulmonary Diseases

BS Lukhele, K Bassey, BA Witika - Current Issues in Molecular Biology, 2023 - mdpi.com
Medicinal plants have been utilized to treat a variety of conditions on account of the
bioactive properties that they contain. Most bioactive constituents from plants are of limited …

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation

M Saresella, CP Zoia, F La Rosa, C Bazzini, G Sala… - Pharmaceuticals, 2023 - mdpi.com
Activation of the NLRP3 inflammasome in response to either exogenous (PAMPs) or
endogenous (DAMPs) stimuli results in the production of IL-18, caspase-1 and IL-1β. These …

Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells

R Mancuso, LA Citterio, S Agostini, I Marventano… - Pharmaceuticals, 2023 - mdpi.com
The anti-hyperglycemic drug glibenclamide (Glb) might represent an interesting therapeutic
option in human neurodegenerative diseases because of its anti-inflammatory activity and …

SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases

S Picciolini, F Rodà, A Gualerzi, V Mangolini, L Forleo… - Analyst, 2023 - pubs.rsc.org
The application of liposomes (LPs) to central nervous system disorders could represents a
turning point in the therapy and quality of life of patients. Indeed, LPs have demonstrated …

Nanomedicine in the treatment of Alzheimer's disease: bypassing the blood-brain barrier with cutting-edge nanotechnology

N Dong, P Ali-Khiavi, N Ghavamikia, SA Pakmehr… - Neurological …, 2024 - Springer
Alzheimer's disease (AD) remains a formidable challenge in the field of neurodegenerative
disorders, necessitating innovative therapeutic strategies. Nanomedicine, leveraging …

Chromatography and Spectroscopic Technique-Based Rapid Characterization of Nano-Carrier Pharmaceuticals

Shamim 1*, T Ali - Pharmaceutical Nanotechnology, 2024 - benthamdirect.com
A nanocarrier is a novel colloidal system whose particle size ranges between 1-100 nm. It is
extensively utilized in drug delivery and various other sectors, such as the pharmaceutical …

Liposomal Pharmaceutical Products: Methods of Analytical Characterization and Quality Control

ZS Shprakh, NI Burdaev, LL Nikolaeva… - Pharmaceutical …, 2024 - Springer
Modern methods of analytical characterization and quality control of liposomal
pharmaceutical products are reviewed. Analytical studies are shown to be extremely …

Honeycomb-inspired SERS nano-bowls for rapid capture and analysis of extracellular vesicles and liposomes in suspension

S Das, JC Tinguely, SAO Obuobi, EM Guerreiro… - bioRxiv, 2023 - biorxiv.org
Nanoscale carriers such as liposomes and extracellular vesicles (EVs) are readily being
explored for personalized medicine or disease prediction and diagnostics, respectively …